原发性胆汁性肝硬化24例临床分析
-
摘要: 目的:探讨原发性胆汁性肝硬化(PBC)的临床诊疗特点.方法:对2012年1月至2013年10月收治的24例PBC患者的临床资料进行回顾性分析.结果:男女比例为1:5,确诊时年龄33~77岁,初诊至确诊时间7 d至5年.患者各项检查指标中,碱性磷酸酶和γ-谷氨酰基转移酶水平明显升高,丙氨酸氨基转移酶和天冬氨酸氨基转移酶升高,血清抗线粒体抗体和/或抗线粒体M2亚型抗体均为阳性.结论:PBC多见于中老年女性,血清碱性磷酸酶、γ-谷氨酰基转移酶水平升高及血清抗线粒体抗体阳性有助于该病的诊断,必要时需行病理学检查.早期予熊去氧胆酸治疗,肝功能可获明显改善.
-
[1] Lindor KD,Gershwin ME,Poupon R,et al.Primary biliary cirrhosis[J].Hepatology,2009,50(1):291-308. [2] European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Management of cholestatic liver diseases[J].J Hepatol,2009,51(2):237-267. [3] Poupon R.Primary biliary cirrhosis:a 2010 update[J].J Hepatol,2010,52(5):745-758. [4] 张福奎,贾继东,王宝恩,等.45例原发性胆汁性肝硬化患者的临床特征[J].中华内科杂志,2002,41(3):163-167. [5] Klein R,Huizenga JR,Gips CH,et al.Antimitochondrial antibody profilesin patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antisubtypes after transplantation[J].J Hepatol,1994,20(2):181-189. [6] Lacerda MA,Shi XH,Zhang FC,et al.Antimitochondrial antibody-negative primary biliary cirrhosis[J].Am J Gastroenterol,1995,90(2):247-249. [7] Muratori P,Muratori L,Ferrari R,et al.Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis[J].Am J Gastroenterol,2003,98(2):431-437. [8] Kim KA,Jeong SH.The diagnosis and treatment of primary biliary cirrhosis[J].Korean J Hepatol,2011,17(3):173-179. [9] Lindor KD,Dickson ER,Baldus WP,et al.Ursodeoxycholic acid in the treatment of primary biliary cirrhosis[J].Gastroenterology,1994,106(5):1284-1290. [10] Parés A,Caballería L,Rodés J,et al.Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis:results of a double-blind controlled multicentric trial.UDCA-Cooperative Group from the Spanish Association for the Study of the Liver[J].J Hepatol,2000,32(4):561-566. [11] Hohenester S,Oude-Elferink RP,Beuers U.Primary biliary cirrhosis[J].Semin Immunopathol,2009,31(3):283-307.
点击查看大图
计量
- 文章访问数: 3676
- HTML全文浏览量: 466
- PDF下载量: 218
- 被引次数: 0